Autonomix
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21 Waterway Ave Ste 300, The Woodlands, ...Phone Number
(713) 588-6150Website
www.autonomix.comRevenue
-Stock Symbol
AMIXIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Autonomix
Autonomix Medical, Inc. is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the peripheral nervous system are diagnosed and treated. The Companys first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with up to 3,000 times greater sensitivity than currently available technologies. The company believes this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. The company is initially developing the company's technology for pancreatic cancer pain and pancreatitis pain, conditions that can cause debilitating pain and need an effective solution. However, the company's technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across aRead more
Autonomix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Autonomix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Autonomix launches new products
Earning: See what the market has to say on Autonomix recently announced quarterly report
Funding: Get notified immidiatlly once Autonomix has new funding data
Check if Autonomix has recently received funding, and reach out quickly before it becomes old news!
Autonomix, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Autonomix is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Autonomix
Click to see if Autonomix had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Autonomix
Find 3 more new buyers
Compare Similar Companies to Autonomix
Compare insights from companies similar to Autonomix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Autonomix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Autonomix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Autonomix.
Autonomix financials insights
Gather financial insights about Autonomix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Stock Offering
$11.1M
Autonomix Tech Stack
A closer look at the technologies used by Autonomix
Most Recent Scoops
Project
Intellectual Property, Legal Affairs, Healthcare Technology
Project
Product Development, Research & Development, Medical Research, Clinical Operations, Healthcare Technology
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Software, Healthcare Technology, Industry Software
Project
Intellectual Property, Legal Affairs, Healthcare Technology
Earnings
Earnings, Finance
Autonomix News & Media
Autonomix Medical Expects $4.9M Warrant Proceeds | AMIX Stock News
An investor has agreed to exercise 857,462 existing warrants at $5.75; closing is expected on or about Aug. 26, subject to customary conditions.Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
THE WOODLANDS, TX, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it has entered into a warrant inducement agreement with an investor (“Investor”) for the immediate exercise of certain outstanding warrants that the Company issued on July 15, 2026 (the “July 2026 Warrants”). Pursuant to a warrant inducement agreement, the Investor has agreeAutonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
Final histology and laboratory analyses support the study’s safety and performance objectivesAutonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award
Recognition honors one of the medical technology industry's most influential innovators, whose career has helped shape modern cardiovascular care
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Autonomix
Sign Up For FreeTo access detailed company insights
Autonomix Medical, Inc. is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the peripheral nervous system are diagnosed and treated. The Companys first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural si... Read More
